Diabetes and long-term risk of mortality coronary and other causes in middle-aged Swedish men: A general population study

Diabetes Care

Volumn 21, Issue 4, 1998, Pages 539-545

  Adlerberth, Annika M ^a   Rosengren, Annika ^a   Wilhelmsen, Lars ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY RISK; DIABETES MELLITUS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; RISK FACTOR; SMOKING; SURVIVAL RATE; SWEDEN;

AGE FACTORS; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHEST PAIN; CHOLESTEROL; COHORT STUDIES; CORONARY DISEASE; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DYSPNEA; HUMANS; MALE; MIDDLE AGED; PAIN; PROSPECTIVE STUDIES; RISK; RISK FACTORS; SMOKING; SWEDEN;

EID: 0031919399     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.4.539     Document Type: Article

References (44)

1. Kannel WB, McGee DL: Diabetes and cardiovascular disease: the Framingham Study. JAMA 241:2035-2038, 1979
2. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H: Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall Study. Br Med J 287:867-870, 1983
3. Kleinman JC, Donahue RP, Harris MI, Finucane FF, Madans JH, Brock DB: Mortality among diabetics in a national sample. Am J Epidemiol 128:389-401, 1988
4. Jarrett RJ, Shipley MJ: Type 2 (non-insulin-dependent) diabetes mellitus and cardiovascular disease: putative association via common antecedents: further evidence from the Whitehall Study. Diabetologia 31:737-740, 1988
5. Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-years cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434-444, 1993
6. Fontbonne AM, Eschwége EM: Insulin and cardiovascular disease: Paris Prospective Study Diabetes Care 14:461-469, 1991
7. Pyöräla K, Laakso M, Uusitupa M: Diabetes and atherosclerosis: an epidemiological view. Diabetes Metab Rev 3:463-524, 1987
8. Panzram G: Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30:123-131, 1987
9. Jarrett RJ: Epidemiology and public health aspects of non-insulin-dependent diabetes mellitus. Epidemiol Rev 11:151-171, 1989
10. Stamler J: Epidemiology, established risk factors, and the primary prevention of coronary heart disease. In Cardiology. Vol. 2. Parmley WW, Chatterjee K, Eds. Philadelphia, Lippincott, 1987, p. 1-41
11. Balkau B, Eschwège E, Papoz L, Richard J-L, Claude J-R, Warnet J-M, Ducimetière P: Risk factors for early death in non-insulin dependent diabetes and men with known glucose tolerance status. BMJ 307:295-299, 1993
12. Schernthaner G: Cardiovascular mortality and morbidity in type 2 diabetes mellitus. Diabetes Res Clin Pract (Suppl.) 31:S3-S13, 1996
13. Fitzgerald AP, Jarrett RJ: Are conventional risk factors for mortality relevant in type 2 diabetes? Diabetic Med 8:475-480, 1991
14. Uusitupa MIJ, Niskanen LK, Siitonen O, Voutilainen E, Pyörälä K: Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 36:1175-1184, 1993
15. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M: NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 43:960-967, 1994
16. Pyörälä K, Uusitupa M, Laakso M, Siitonen O, Niskanen L, Rönnemaa T: Macrovascular complications in relation to hyperinsulinaemia in non-insulin-dependent diabetes mellitus. Diabete Metab 13:345-349, 1987
17. Muggeo M, Verlato G, Bonora E, Ciano F, Moghetti P, Eastman R, Crepaldi G, de Marco R: Long-term instability of fasting plasma glucose predicts mortality in elderly NIDDM patients: the Verona Diabetes Study. Diabetologia 38:672-679, 1995
18. Stehouwer CDA, Nauta JJP, Zeldenrust GC, Hackeng WHL, Donker AJM, Ottolander GJH: Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 340:319-323, 1992
19. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321, 1988
20. Ganda OP, Arkin CF: Hyperfibrinogenemia: an important risk factor for vascular complications in diabetes. Diabetes Care 15:1245-1250, 1992
21. Kannel WB, McGee DL: Diabetes and cardiovascular risk factors: the Framingham Study. Circulation 59:8-13, 1979
22. Rosengren A, Welin L, Tsipogianni A, Wilhelmsen L: Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study. BMJ 299:1127-1131, 1989
23. Fontbonne A, Eschwège E, Cambien F, Richard JL, Ducimetière P, Thibult N, Warnet JM, Claude JR, Rosselin GE: Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Diabetologia 32:300-304, 1989
24. Morrish NJ, Stevens LK, Head J, Fuller JH, Jarrett RJ, Keen H: A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics) II: associated risk factors. Diabetologia 33:542-548, 1990
25. Wilhelmsen L, Berglund G, Elmfeldt D, Tibblin G, Wedel H, Pennert K, Vedin A, Wilhelmsson C, Werkö L: The multifactor primary prevention trial in Göteborg, Sweden. Eur Heart J 7:279-288, 1986
26. Rose GA, Blackburn H: Cardiovascular Survey Methods. Geneva, World Health Organization, 1968, p. 64-85
27. Leffler HH: Estimation of cholesterol in serum. Am J Clin Pathol 31:310-313, 1959
28. Elmfeldt D, Wilhelmsen L, Tibblin G, Vedin A, Wilhelmsson C, Bengtsson C: Registration of myocardial infarction in the city of Göteborg, Sweden. J Chronic Dis 28:173-186, 1975
29. Cook DG, Shaper AG, Macfarlane PW: Using the WHO (Rose) angina questionnaire in cardiovascular epidemiological studies. Int J Epidemiol 18:607-613, 1989
30. Hagman M, Wilhelmsen L, Wedel H, Pennert K: Risk factors for angina pectoris in a population study of Swedish men. J Chronic Dis 40:265-275, 1987
31. Kleinbaum DG, Kupper LL, Morgenstern H: Epidemiologic Research: Principles and Quantitative Methods, Belmont, CA, Lifetime Learning Publications, 1982, p. 422-432
32. Ohlsson LO, Larsson B, Eriksson H, Svärdsudd K, Welin L, Tibblin G: Diabetes mellitus in Swedish midddle-aged men: the study of men born in 1913 and 1923. Diabetologia 30:386-393, 1987
33. Harris MI, Hadden WC, Knowler WC, Bennet PH: Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20-74 years. Diabetes 36:523-534, 1987
34. Barrett-Connor E: The prevalence of diabetes mellitus in an adult community as determined by history or fasting hyperglycemia. Am J Epidemiol 111:705-712, 1980
35. Taskinen MR: Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus. Diabetes 41 (Suppl. 2):12-17, 1992
36. Austin MA, King MC, Vranizan KM, Krauss RM: Atherogenic lipoprotein phenotype. Circulation 82:495-506, 1990
37. Reaven GM, Ida Chen YD, Jeppesen J, Maheux P, Krauss RM: Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J Clin Invest 92:141-146, 1993
38. Stewart MW, Laker MF, Dyer RG, Game F, Mitcheson J, Winocour PH, Alberti KGMM: Lipoprotein compositional abnormalities and insulin resistance in type II diabetic patients with mild hyperlipidemia. Arterioscler Thromb 13:1046-1052, 1993
39. Goodkin G: Mortality factors in diabetics. J Occup Med 17:716-721, 1975
40. Suarez L, Barrett-Connor E: Interaction between cigarette smoking and diabetes mellitus in the prediction of death attributed to cardiovascular disease. Am J Epidemiol 120:670-675, 1984
41. 4L Fontbonne A, Thibult N, Eschwège E, Ducimetière P: Body fat distribution and coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes mellitus: the Paris Prospective Study, 15-year follow-up. Diabetologia 35:464-468, 1992
42. Sasaki A, Horiuchi N, Hasegawa K, Uehara M: Mortality and causes of death in type 2 diabetic patients: a long-term follow-up study in Osaka District, Japan. Diab Res Clin Pract 7:33-40, 1989
43. Pyörälä K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G: Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 20:614-620, 1997
44. American Diabetes Association: Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes (Consensus Statement). Diabetes Care 12:573-579, 1989